Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam M Wiseman

Showing results (131-140 of 179) with videos related to

Pageof 18
Sort By:
Annals of Surgical Oncology|July 10, 2008
Molecular phenotyping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosisSam M Wiseman, Adrienne Melck, Hamid Masoudi, et al.
Annals of Surgical Oncology|September 21, 2007
Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancerAdrienne Melck, Hamid Masoudi, Obi L Griffith, et al.
American Journal of Surgery|March 15, 2020
Intraoperative parathyroid hormone measurement during parathyroidectomy for treatment of primary hyperparathyroidism: When should you end the operation?Nicole T J J Mak, Jennifer Li, Elizaveta Vasilyeva, et al.
American Journal of Surgery|May 15, 2010
Determinants of Tc-99m sestamibi SPECT scan sensitivity in primary hyperparathyroidismTodd W Swanson, Simon K Chan, Steven J Jones, et al.
Head & Neck|July 29, 2003
Anaplastic transformation of thyroid cancer: review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapySam M Wiseman, Thom R Loree, Nestor R Rigual, et al.
Annals of Surgical Oncology|November 23, 2006
Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatmentSam M Wiseman, Hamid Masoudi, Paddy Niblock, et al.
Cancer|March 17, 2005
Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survivalSam M Wiseman, Nikita Makretsov, Torsten O Nielsen, et al.
Cureus|April 8, 2020
Treatment for Recurrent Differentiated Thyroid Cancer: A Canadian Population Based ExperienceAria Shokoohi, Eric Berthelet, Sabrina Gill, et al.
The Journal of Pathology|April 20, 2012
Coordinated expression of galectin-3 and caveolin-1 in thyroid cancerJay Shankar, Sam M Wiseman, Fanrui Meng, et al.
Archives of Surgery (Chicago, Ill. : 1960)|August 22, 2007
Identification of molecular markers altered during transformation of differentiated into anaplastic thyroid carcinomaSam M Wiseman, Obi L Griffith, Shaun Deen, et al.
Pageof 18

Showing results (131-140 of 179) with videos related to

Sort By:
Pageof 18
Annals of Surgical Oncology|July 10, 2008
Molecular phenotyping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosisSam M Wiseman, Adrienne Melck, Hamid Masoudi, et al.
Annals of Surgical Oncology|September 21, 2007
Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancerAdrienne Melck, Hamid Masoudi, Obi L Griffith, et al.
American Journal of Surgery|March 15, 2020
Intraoperative parathyroid hormone measurement during parathyroidectomy for treatment of primary hyperparathyroidism: When should you end the operation?Nicole T J J Mak, Jennifer Li, Elizaveta Vasilyeva, et al.
American Journal of Surgery|May 15, 2010
Determinants of Tc-99m sestamibi SPECT scan sensitivity in primary hyperparathyroidismTodd W Swanson, Simon K Chan, Steven J Jones, et al.
Head & Neck|July 29, 2003
Anaplastic transformation of thyroid cancer: review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapySam M Wiseman, Thom R Loree, Nestor R Rigual, et al.
Annals of Surgical Oncology|November 23, 2006
Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatmentSam M Wiseman, Hamid Masoudi, Paddy Niblock, et al.
Cancer|March 17, 2005
Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survivalSam M Wiseman, Nikita Makretsov, Torsten O Nielsen, et al.
Cureus|April 8, 2020
Treatment for Recurrent Differentiated Thyroid Cancer: A Canadian Population Based ExperienceAria Shokoohi, Eric Berthelet, Sabrina Gill, et al.
The Journal of Pathology|April 20, 2012
Coordinated expression of galectin-3 and caveolin-1 in thyroid cancerJay Shankar, Sam M Wiseman, Fanrui Meng, et al.
Archives of Surgery (Chicago, Ill. : 1960)|August 22, 2007
Identification of molecular markers altered during transformation of differentiated into anaplastic thyroid carcinomaSam M Wiseman, Obi L Griffith, Shaun Deen, et al.
Pageof 18